T2 Biosystems T2 Biosystems Q2 Revenues More Than Double, Beat Estimates The firm sold three T2Dx instruments in the quarter and saw an annualized run rate of sepsis tests of $98,000 per legacy instrument. T2 Biosystems Advancing Pipeline, Accelerating Instrument Placement Strategy Premium The company is working to transition its instruments sold in the US from COVID-19 testing to sepsis testing and increase its installed base. T2 Biosystems Q1 Revenues Nearly Triple Product revenues were up 345 percent, as the firm increased US sepsis test utilization by 85 percent and sold four T2Dx instruments. T2 Biosystems Q4 Revenues Jump 152 Percent on Strong Product Sales The company said that it sold 57 T2Dx instruments in 2020, including 47 in the US, more than doubling its US installed base. T2 Biosystems Preliminary Q4 Revenues Grow 155 Percent, Miss Estimates The firm also announced the amendment of the terms of a loan with CRG, a global healthcare investor. Nov 4, 2020 T2 Biosystems Q3 Revenues Triple, Beat Estimates Sep 30, 2020 BARDA Exercises $10.5M Option on T2 Bio Contract Aug 31, 2020 T2 Biosystems Gets FDA EUA for SARS-CoV-2 Molecular Diagnostic Test Aug 13, 2020 HelixBind Aims to Circumvent Culture With Rapid Technology to Detect Bloodstream Infections Premium Aug 11, 2020 T2 Biosystems Q2 Revenues Up 41 Percent, Beat Estimates Jul 1, 2020 T2 Biosystems Preliminary Q2 Revenues Up About 40 Percent; Firm Launches COVID-19 Test Jun 19, 2020 People in the News: Geoffrey Oxnard, Christopher O'Connell, Thierry Bernard, More Jun 17, 2020 T2 Biosystems Regains Compliance With Nasdaq Listing Requirements May 5, 2020 T2 Biosystems Q1 Revenues Jump 43 Percent Apr 9, 2020 T2 Biosystems Receives Nasdaq Warning Letter Mar 24, 2020 T2 Biosystems Preliminary Q1 Revenues Spike; Firm Suspends 2020 Guidance, Licenses COVID-19 Test Feb 25, 2020 New T2 Biosystems CEO Plans to Shrink Costs, Sharpen Sales Strategy Premium Feb 24, 2020 T2 Biosystems Q4 Revenues Jump 71 Percent, Miss Analyst Estimates Jan 9, 2020 T2 Biosystems Preliminary Q4 Revenues up 67 Percent, Firm Announces CEO Transition Nov 20, 2019 T2 Biosystems Gets CE Mark for Direct-From-Blood Antimicrobial Resistance Panel Nov 12, 2019 T2 Biosystems Q3 Revenues Drop 36 Percent; Firm Suffers Ransom Cyberattack Sep 25, 2019 T2 Biosystems Inks Distribution Deal in Puerto Rico, US Virgin Islands Sep 13, 2019 BARDA Contract Win, Unprecedented CMS Incentive Expected to Catalyze T2 Biosystems Growth Premium Jul 18, 2017 T2 Biosystems Receives CE Mark for Bacterial Panel May 2, 2017 T2 Biosystems' Gain in Q1 Product Sales Offset by Decline in Research Revenue Load More Breaking News MDxHealth Q3 Revenues Grow 23 Percent BioMérieux Q3 Revenues Increase 11 Percent, Firm Raises 2021 Guidance Germline Cancer Risk Genes May Hold Rhabdomyosarcoma Survival Clues, Study Suggests Danaher Q3 Revenues Rise 23 Percent, Beat Wall Street Estimates Horse Genetics Study Reveals Origins of Domestication, Use in Human Culture Rady Children's Team Presents Genomic Medicine Management Tool at ASHG The Scan Guidelines for Ancient DNA Work More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature. And Cleared A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times. Suit Over Allegations The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director. Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.